The “decompressing stoma - neoadjuvant Folfox chemotherapy - colectomy” strategy for non-metastatic obstructive colon cancer: A French retrospective multi-institutional case series | Synapse
March 3, 2026
The “decompressing stoma - neoadjuvant Folfox chemotherapy - colectomy” strategy for non-metastatic obstructive colon cancer: A French retrospective multi-institutional case series
Key Points
Decompressing stoma combined with neoadjuvant Folfox chemotherapy offers effective treatment for obstructive colon cancer.
The study analyzed outcomes from multiple institutions, highlighting significant success in managing non-metastatic cases.
This analysis utilized a retrospective multi-institutional approach to yield comprehensive insights into treatment effectiveness.
The findings support the potential for improved patient outcomes with this combined treatment strategy in clinical practice.